IRIS
PAPPALARDO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.269
AS - Asia 3.629
EU - Europa 3.185
SA - Sud America 828
AF - Africa 589
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 11
AN - Antartide 1
Totale 15.562
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.020
SG - Singapore 1.895
CN - Cina 1.171
IT - Italia 887
BR - Brasile 708
IE - Irlanda 596
RU - Federazione Russa 438
CI - Costa d'Avorio 437
UA - Ucraina 388
CA - Canada 205
DE - Germania 199
VN - Vietnam 177
FI - Finlandia 142
KR - Corea 110
FR - Francia 96
GB - Regno Unito 85
NL - Olanda 61
BE - Belgio 60
SN - Senegal 58
AT - Austria 56
TR - Turchia 41
AR - Argentina 39
IN - India 38
SE - Svezia 38
AU - Australia 36
BD - Bangladesh 31
MX - Messico 25
CZ - Repubblica Ceca 24
EC - Ecuador 24
PL - Polonia 24
ES - Italia 21
IQ - Iraq 20
JP - Giappone 20
ZA - Sudafrica 20
NG - Nigeria 18
UZ - Uzbekistan 17
BJ - Benin 16
CH - Svizzera 16
CO - Colombia 15
IR - Iran 15
NZ - Nuova Zelanda 14
GR - Grecia 13
ID - Indonesia 13
PK - Pakistan 13
HK - Hong Kong 11
KE - Kenya 11
VE - Venezuela 11
PT - Portogallo 9
PY - Paraguay 9
EU - Europa 8
BG - Bulgaria 7
EG - Egitto 7
LB - Libano 7
TN - Tunisia 7
TW - Taiwan 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
PE - Perù 6
HU - Ungheria 5
IL - Israele 5
JM - Giamaica 5
KZ - Kazakistan 5
LT - Lituania 5
MA - Marocco 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
NP - Nepal 4
AZ - Azerbaigian 3
ET - Etiopia 3
GA - Gabon 3
JO - Giordania 3
PS - Palestinian Territory 3
RO - Romania 3
BB - Barbados 2
BO - Bolivia 2
KW - Kuwait 2
NO - Norvegia 2
OM - Oman 2
SI - Slovenia 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
LV - Lettonia 1
ME - Montenegro 1
MN - Mongolia 1
MU - Mauritius 1
Totale 15.556
Salva come PNG Salva come JPEG
Città #
Dallas 1.401
Santa Clara 1.069
Singapore 1.045
Chandler 752
Dublin 580
Abidjan 437
Jacksonville 407
Chicago 320
Houston 296
Catania 256
Boardman 248
Hefei 236
Ashburn 226
Beijing 182
Cambridge 163
Lawrence 159
Andover 152
Moscow 142
Los Angeles 141
Nanjing 139
Toronto 119
Seoul 103
Des Moines 96
Helsinki 94
Civitanova Marche 86
Nuremberg 82
Brussels 58
Dakar 58
San Mateo 58
São Paulo 57
Nanchang 56
Ho Chi Minh City 55
Rome 55
Wilmington 49
Lappeenranta 43
Bremen 42
Council Bluffs 42
Hanoi 40
The Dalles 39
Buffalo 38
Columbus 36
Hebei 36
New York 35
Shenyang 35
Ottawa 31
Saint Petersburg 31
Vienna 30
Jiaxing 29
Dong Ket 28
Tianjin 27
Munich 25
Belo Horizonte 23
Rio de Janeiro 21
Changsha 20
Seattle 20
Amsterdam 19
Brno 19
Falls Church 19
Montreal 19
Pozzallo 19
Abuja 18
Kayseri 18
Naples 18
Denver 17
Warsaw 17
Cotonou 16
Palermo 16
Shanghai 16
Boston 15
Tokyo 15
Acireale 14
Melbourne 14
Zhengzhou 14
Norwalk 13
Porto Alegre 13
Salvador 13
San Francisco 13
San Giovanni la Punta 13
Atlanta 12
Grafing 12
Padova 12
Redondo Beach 12
Tehran 12
Brooklyn 11
Chennai 11
Hong Kong 11
L'Île-Saint-Denis 11
Messina 11
Phoenix 11
Stockholm 11
Brasília 10
Haiphong 10
Nairobi 10
Reggio Calabria 10
Turin 10
Washington 10
Ankara 9
Campinas 9
Cape Town 9
Mascalucia 9
Totale 10.649
Salva come PNG Salva come JPEG
Nome #
((2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 280
Parallel Pair-Wise Interaction for Multi-Agent Immune Systems Modelling 219
2DIs: a SBML compliant web platform for the design and modeling of immune system interactions 155
A MapReduce Based Tool for the Analysis and Discovery of Novel Therapeutic Targets 154
A Credibility Assessment Plan for an In Silico Model that Predicts the Dose-Response Relationship of New Tuberculosis Treatments 148
Computational modelling in melanoma for novel drug discovery 146
A methodological approach for using High-Level Petri Nets to model the immune system response 146
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 139
A biological optimization problem on the Grid 138
Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis 137
Agent based modeling of the immune system: NetLogo, a promising framework 132
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis 131
R- ed S-LP2: sintesi, molecular docking e valutazione farmacologica 131
iAtheroSim: atherosclerosis process simulator on smart devices. 129
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 129
A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets 127
A MapReduce tool for in-depth analysis of KEGG pathways: identification and visualization of therapeutic target candidates 125
Agent based modeling of relapsing multiple sclerosis: A possible approach to predict treatment outcome 124
Boosting multiple sclerosis lesion segmentation through attention mechanism 123
A novel paradigm for cell and molecule interaction ontology: from the CMM model to IMGT-ONTOLOGY 123
A computational model to predict the immune system activation by citrus derived vaccine adjuvants 120
The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis 119
A modeling framework for immune-related diseases 118
In silico clinical trials: concepts and early adoptions 116
Nose-to-Brain Drug Delivery and Physico-Chemical Properties of Nanosystems: Analysis and Correlation Studies of Data from Scientific Literature 113
A genetic algorithm for shortest path motion problem in three dimensions 113
Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus 113
An agent based modeling approach for the analysis of tuberculosis - Immune system dynamics 113
Analysis of vaccine's schedules using models, 112
DNA methylation and gene expression in melanoma: A large-scale integrated analysis 111
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 111
A model of cytotoxic T antitumor activation stimulated by pulsed dendritic cells 109
Agent based simulations in disease modeling Comment on “Towards a unified approach in the modeling of fibrosis: A review with research perspectives” by Martine Ben Amar and Carlo Bianca 109
Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer 107
Advancing PFAS risk assessment: Integrative approaches using agent-based modelling and physiologically-based kinetic for environmental and health safety 106
A computational approach based on the colored Petri net formalism for studying multiple sclerosis 105
Agent based modeling of humoral response to atherogenesis 104
PEAK: A Clever Python Tool for Exploratory, Regression, and Classification Data. A Case Study for COVID-19 102
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS) 101
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 101
Advances in Computational Immunology 99
Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza 98
Agent based modeling of lung metastasis-immune system competition 97
Credibility of In Silico Trial Technologies - A Theoretical Framing 97
SimB16: modeling induced immune system response against B16-melanoma 96
In silico design of recombinant multi-epitope vaccine against influenza A virus 96
Evaluation of the efficacy of RUTI and ID93/GLA-SE vaccines in tuberculosis treatment: in silico trial through UISS-TB simulator 95
Combining Parallel Genetic Algorithms and Machine Learning to Improve the Research of Optimal Vaccination Protocols 94
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 94
Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB 94
Toward computational modelling on immune system function 93
Design and optimization of PEGylated nanoparticles intended for Berberine Chloride delivery 92
Optimization of HAART by means of Genetic Algorithms and agent based models of HIV infection 91
Enhancing Multiple Sclerosis Lesion Segmentation in Multimodal MRI Scans with Diffusion Models 90
Cancer immunoprevention: What can we learn from in silico models? 90
A hybrid model of the immune response against lung metastases 90
BIOESOnet: A Tool for the Generation of Personalized Human Metabolic Pathways from 23andMe Exome Data 90
GPU accelerated analysis of treg-teff cross regulation in relapsing-remitting multiple sclerosis 90
Current issues in tumor immunology 89
Modeling the competition between lung metastases and the immune system using agents 89
Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations 89
Agent based modeling of atherosclerosis: a concrete help in personalized treatments 88
Reverse Vaccinology for Influenza A Virus: From Genome Sequencing to Vaccine Design 87
Combining cellular automata and lattice Boltzmann method to model multiscale avascular tumor growth coupled with nutrient diffusion and immune competition 87
Analysis of vaccine's schedules using models, 86
A multi-step and multi-scale bioinformatic approach to investigate potential source of cross-reactive immunity against SARS-CoV-2 UK variant 86
Induction of T cell memory by a dendritic cell vaccine: a computational model 85
Using Continuous Petri Nets to predict the impact of microRNA analysis in PI3K/Akt and MAPK Signaling Pathways 85
Computational models to predict disease course and treatment response in multiple sclerosis 85
Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles 84
SHyFTA, a Stochastic Hybrid Fault Tree Automaton for the modelling and simulation of Dynamic Reliability problem 84
Modelling Vaccine Protocols 83
Sexual risk behaviours 83
Mathematical and computational models in tumor immunology 82
Persistence analysis in a Kolmogorov-type model for cancer-immune system competition 81
PETAL: A Python tool for deep analysis of biological pathways 81
In silico evaluation of daclizumab and vitamin D effects in multiple sclerosis using agent based models 80
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review) 80
Optimal vaccination schedule search using genetic algorithm over MPI technology 79
Predictive models in tumor immunology 79
Introducing scale factor adjustments on agent-based simulations of the immune system 79
Model verification tools: a computational framework for verification assessment of mechanistic agent-based models 78
Computational modeling of brain pathologies: the case of multiple sclerosis 78
Compartmental mathematical modeling of immune system - melanoma competition 78
The dynamic-to-static conversion of Dynamic Fault Trees using Stochastic Dependency Graphs and Stochastic Activity Networks 78
Generation of digital patients for the simulation of tuberculosis with UISS-TB 78
Computational modelling and simulation for immunotoxicity prediction induced by skin sensitisers 77
GRIDUISS - A grid based universal immune system simulator framework 77
How can we accelerate COVID-19 vaccine discovery? 77
Vaccine protocols optimization: in silico experiences 76
Universal Immune System Simulator framework (UISS) 76
ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design, and optimization 76
Searching of optimal vaccination schedules 75
Mathematical modeling of biological systems 75
Modeling Cutaneous Leishmaniasis: Insights into M1/M2 Macrophage Dynamics Using the Universal Immune System Simulator 74
Computational simulations of the immune system for personalized medicine: state of the art and challenges 74
Translational immunomics of cancer immunoprevention 74
Cancer vaccines: state of the art of the computational modeling approaches 74
Modeling biology spanning different scales: An open challenge 73
Computational models as novel tools for cancer vaccines 73
Totale 10.197
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.693
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.693
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021337 0 0 0 0 0 34 89 5 81 14 66 48
2021/20221.182 143 158 7 19 190 11 166 49 103 21 44 271
2022/20232.112 183 120 28 251 194 364 12 342 464 18 71 65
2023/20241.514 53 382 73 49 29 230 34 113 14 209 202 126
2024/20254.183 97 602 218 224 921 511 305 145 250 376 258 276
2025/20264.849 499 534 1.647 575 1.241 353 0 0 0 0 0 0
Totale 15.934